1832 Asset Management L.P.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 944388
TORONTO, A6
Position in REGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,545,280
-$165,845,535 QoQ
Shares Held
2,000
-99.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 20261832 Asset Management L.P. holds $136,938,098 across 8 Biotechnology names. REGN ranks #7 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
84,200 | $61,487,050 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
356,400 | $26,466,264 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
143,800 | $24,305,076 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
42,600 | $11,004,432 | |
| 5 | INCY |
Incyte Corp
|
74,053 | $6,969,868 | |
| 6 | INSM |
INSMED Inc
|
28,900 | $4,725,728 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
2,000 | $1,545,280 | |
| 8 | EPRX |
Eupraxia Pharmaceuticals Inc.
|
60,000 | $434,400 |
All Filings in REGN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,545,280 | 2,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $167,390,815 | 216,864 | Shares | Sole | 2026-02-13 | |
| 2025-03-31 | $1,326,809 | 2,092 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,409,923 | 4,787 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,116,655 | 3,916 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,296,500 | 2,185 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,700,746 | 2,806 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,979,665 | 2,254 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,564,446 | 1,901 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,591,566 | 2,215 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,307,932 | 8,894 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,154,369 | 2,986 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $2,506,797 | 3,639 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,532,400 | 4,284 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,335,516 | 3,344 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $434,519 | 718 | Shares | Sole | 2021-11-15 | |
| 2020-12-31 | $2,463,861 | 5,100 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,854,878 | 5,100 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $18,896,595 | 30,300 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||